ScenPro to convert FDA cross-center clinical data for comparisons

Female-owned and Texas-based ScenPro has landed a contract to convert legacy FDA clinical trial data into standardized formats. The goal of the effort, which encompasses the varied databases that cross the drug, biologics and device centers, is to aid comparative effectiveness research. ScenPro will work with consultancy Octagon Research to convert the data to such standard formats as CDISC for analysis and for merging with data from new and ongoing trials. ScenPro release